About Cell Therapies

Bev has over 20 years’ experience across the Australian and global biopharmaceutical & healthcare sectors. She holds a PhD in molecular medicine with additional qualifications in genetic counselling, project management and decision analysis.

Bev commenced her career with Postdoctoral roles in cancer research at Memorial Sloan Kettering Cancer Centre and the Peter MacCallum Cancer Centre, before moving to genetic counselling practice and then commercial roles in research & development, portfolio management and strategic partnerships in the pharmaceutical industry.

Colin McLean is Chief Operating Officer at Cell Therapies Pty Ltd, with more than 15 years of experience across regulated manufacturing, quality and operational leadership.

He oversees manufacturing, supply chain, validation and project delivery, with a focus on building reliable, scalable operations that support both clinical and commercial programs.

Colin’s background spans manufacturing, Quality Control, Quality Assurance, technology transfer, validation and regulatory compliance across a wide range of advanced therapy programs. He has led multidisciplinary teams in Australia and the UK and has extensive experience working in complex GMP-regulated environments.

He holds a Master’s in Transfusion, Transplantation and Tissue Banking from the University of Edinburgh and is focused on strengthening operational performance, developing high-performing teams and supporting long-term partnerships across the advanced therapies sector.

Matthew brings a proven track record at the unique intersection of finance, data, and growth strategy. He is CPA-qualified and an active member of CPA Australia, with academic foundations in accounting and commercial law. Matthew is a strong believer that effective decision-making starts with great data.

Kate has 20 years of experience working in People and Culture roles across health, finance and professional services. She is passionate about supporting people to be their best at work and executes this through building strong relationships, understanding and alternative perspectives.

Bindhu leads our QA, QC and Validation teams, with overall responsibility for the QMS and GMP compliance at Cell Therapies. She has over 20 years of experience in the pharma industry and is a passionate supporter of embedding Quality and Continuous improvement.

As co-founder of Cell Therapies and former Chief Scientific Officer, Dominic serves as a strategic advisor, leveraging deep industry expertise in the manufacture and delivery of innovative cell-based therapies for clinical trials and commercial supply. Dominic also holds an appointment at the Peter MacCallum Cancer Centre as Executive Director-Business Ventures, overseeing the Centre of Excellence in Cellular Immunotherapy, Theranostics, and Pathology.

Deirdre experience includes Chief Operating Officer at Arts Centre Melbourne where her responsibilities include Finance, IT and digital, Facilities Management, Strategic Planning, Risk Management and more. Deirdre was on the Peter MacCallum Cancer Centre Board until July 2032, and is Chair of the Audit and Risk Management Committee.

Deirdre experience includes Chief Operating Officer at Arts Centre Melbourne where her responsibilities include Finance, IT and digital, Facilities Management, Strategic Planning, Risk Management and more. Deirdre was on the Peter MacCallum Cancer Centre Board until July 2032, and is Chair of the Audit and Risk Management Committee.

Matt O’Keefe is a Board Director of the Peter MacCallum Cancer Centre and the Chairman of the Finance Committee. With more than 25 years’ technology, finance and assurance experience, he specialises in technology advisory and offers numerous services across technology governance and risk, project management, and more.